Biden admin to focus on health disparities To view this email as a web page,
click here | | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
Vir, GSK unveil final data for COVID-19 antibody en route to 2021 filing AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost—and looks to add mRNA to the menu With ACA safe, Biden administration putting focus on health disparities Not done yet: Roche nets new FDA COVID-19 authorization for point-of-care PCR screening test COVID-19 tracker: MSF calls on BioNTech to share vaccine know-how; U.S. won't immediately donate AZ doses UPDATED Coronavirus tracker: Study ties birthday gatherings to increased COVID spread Featured Story | By Amirah Al Idrus With final phase 3 data in hand, Vir Biotechnology and GlaxoSmithKline are seeking full approval for their COVID-19 antibody by the end of the year. The study found that the treatment, sotrovimab, slashed hospitalizations and deaths by 79% in adults with mild to moderate COVID-19 who were at high risk of their disease becoming severe. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner COVID-19 production pacts have elevated the profile of numerous biopharmas during the pandemic, and that's certainly true for AstraZeneca and Novavax's partner SK Bioscience. The company is now channeling its recent momentum into a sizable manufacturing expansion at home. read more By Paige Minemyer With the Affordable Care Act legally safe—for now—the Biden administration is turning its eyes to addressing health inequity. read more By Conor Hale Though the demand for COVID-19 testing is beginning to wind down, Roche is aiming to make the most of what’s left, with a new molecular test designed to help healthcare workers track the pandemic over the long haul. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner International humanitarian group MSF called on BioNTech to share its vaccine technology with developing countries. AstraZeneca vaccine doses will not be included in the first donations from the U.S. to other countries. And more headlines. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more | | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
|
|
